Login to Your Account



Biosurgery Holders Aim To Block Genzyme's Consolidation Bid

By Randall Osborne


Thursday, June 5, 2003
A pair of leading shareholders in Genzyme Biosurgery have taken to federal court their move to block the forced sale of Biosurgery stock, disclosed last month by Genzyme Corp. as part of a plan to consolidate all three divisions into a single-stock trading unit. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription